Amanda Jezek, Senior Vice President of Public Policy and Government Relations, Lisa Cox, Director of Government Relations, and Eli Briggs, Director of Public Policy from Infectious Diseases Society of America (IDSA) joined us for a discussion led by Jenny Luray, Research!America’s Vice President of Strategy and Communications, about antimicrobial resistance –a public health challenge only […]
Clay Alspach, Principal at Leavitt Partners and Former Chief Health Counsel of the House Energy & Commerce Committee, joined us for a closed door discussion about implementation of the prescription drug reimbursement and coverage provisions in the Inflation Reduction Act. This was a members-only, off-the-record discussion.
We were joined by Caroline Montojo, PhD, President of the Dana Foundation. Dr. Montojo discussed highlights from the 2022 national survey we commissioned in partnership with the Dana Foundation, on brain health and brain health research. Additionally, she shed light on the Foundation’s vision for a future in which brain science benefits from and reflects […]
Emily Holubowich, VP of Federal Advocacy at the American Heart Association, joined us for a close-door discussion on the President’s Fiscal Year 2024 budget request. She also discussed the outlook for FY24 appropriations generally, in what can only be described as an indescribable federal funding environment. This was a members-only, off-the-record discussion.
Established in 1996, the Advocacy Awards are an annual, signature event for Research!America and the research community. This year’s event will be high-energy, engaging, and inspiring. Meet the 2023 Honorees.
Yvette Seger, Director of Science Policy, Federation of American Societies for Experimental Biology (FASEB) joined us to give us a crash course on how you can weigh in on policy at NIH and other research agencies through Requests for Information (RFIs). It’s easier than you think! Watch the recording and view the slides.
Dr. Nora Volkow, Director of the National Institute on Drug Abuse (NIDA), joined us for a candid conversation about the opioid crisis. Where are we on the arduous path to ending this crisis? How is public and private sector-fueled research contributing? Your participation added value to a conversation focused on a battle our nation and […]
Nick Bath, Partner at Manatt, Phelps & Phillips joined us for a closed-door discussion on the intersection of Food and Drug Administration and Center for Medicare and Medicaid Services decision-making as the controversy surrounding “coverage with evidence” development for new Alzheimer’s drugs continues. This was a members-only, off-the-record discussion.
Join Research!America, Global Health Technologies Coalition (GHTC), and other GH community partners for a conversation with David Bowen, special advisor at the Advanced Research Projects Agency for Health (ARPA-H). We’ve asked David to give an overview of ARPA-H and how this exciting new USG agency differs from others, and to discuss the ways in which […]
Tish Hevel, CEO of The Brain Donor Project, joined us for a discussion on brain donation. In concert with the NeuroBioBank of the National Institutes of Health, The Brain Donor Project is the leading organization working to increase awareness and facilitate brain donation in pursuit of faster neurological scientific breakthroughs. Tish helped illuminate the process […]
Research is only as good as the data informing it. Mary Pittman, President and CEO, Public Health Institute (PHI) joined us for a discussion focused on what good data really looks like in the context of public health research; tools and approaches to make data more precise; and how social determinants of health and other […]
Regina Barzilay, PhD, Professor of Electrical Engineering and Computer Science at MIT, joined us to discuss the potential – and potential pitfalls – as health-focused artificial intelligence (AI) evolves. Dr. Barzilay answered questions and shared her own story: and how confronting breast cancer convinced her AI can dramatically improve the diagnosis and treatment of disease. […]
